nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanethidine—CYP3A4—prostate cancer	0.388	1	CbGaD
Guanethidine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.117	0.207	CbGbCtD
Guanethidine—CYP3A4—Bicalutamide—prostate cancer	0.0616	0.109	CbGbCtD
Guanethidine—CYP3A4—Estramustine—prostate cancer	0.0573	0.101	CbGbCtD
Guanethidine—CYP3A4—Abiraterone—prostate cancer	0.0511	0.09	CbGbCtD
Guanethidine—CYP3A4—Flutamide—prostate cancer	0.0511	0.09	CbGbCtD
Guanethidine—CYP3A4—Cabazitaxel—prostate cancer	0.0378	0.0666	CbGbCtD
Guanethidine—CYP3A4—Estrone—prostate cancer	0.0369	0.0651	CbGbCtD
Guanethidine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0329	0.058	CbGbCtD
Guanethidine—CYP3A4—Conjugated Estrogens—prostate cancer	0.0241	0.0426	CbGbCtD
Guanethidine—CYP3A4—Mitoxantrone—prostate cancer	0.0219	0.0387	CbGbCtD
Guanethidine—CYP3A4—Estradiol—prostate cancer	0.0212	0.0374	CbGbCtD
Guanethidine—CYP3A4—Prednisone—prostate cancer	0.0182	0.0321	CbGbCtD
Guanethidine—CYP3A4—Etoposide—prostate cancer	0.0138	0.0244	CbGbCtD
Guanethidine—CYP3A4—Docetaxel—prostate cancer	0.0127	0.0223	CbGbCtD
Guanethidine—CYP3A4—Doxorubicin—prostate cancer	0.00944	0.0166	CbGbCtD
Guanethidine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—prostate cancer	0.0002	0.00444	CbGpPWpGaD
Guanethidine—SLC6A2—NRF2 pathway—CYP2A6—prostate cancer	0.0002	0.00443	CbGpPWpGaD
Guanethidine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—prostate cancer	0.000194	0.0043	CbGpPWpGaD
Guanethidine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—prostate cancer	0.000189	0.00419	CbGpPWpGaD
Guanethidine—CYP3A4—Estrogen metabolism—GSTM1—prostate cancer	0.000186	0.00413	CbGpPWpGaD
Guanethidine—SLC6A2—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000184	0.00408	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000184	0.00407	CbGpPWpGaD
Guanethidine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—prostate cancer	0.000182	0.00404	CbGpPWpGaD
Guanethidine—CYP3A4—Estrogen metabolism—CYP1A1—prostate cancer	0.000177	0.00391	CbGpPWpGaD
Guanethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A5—prostate cancer	0.000175	0.00389	CbGpPWpGaD
Guanethidine—SLC6A2—NRF2 pathway—SLC5A5—prostate cancer	0.000174	0.00385	CbGpPWpGaD
Guanethidine—CYP3A4—Oxidation by Cytochrome P450—CYP3A5—prostate cancer	0.000173	0.00384	CbGpPWpGaD
Guanethidine—CYP3A4—Tryptophan metabolism—CYP2C18—prostate cancer	0.000171	0.00378	CbGpPWpGaD
Guanethidine—CYP3A4—Irinotecan Pathway—APC—prostate cancer	0.000169	0.00375	CbGpPWpGaD
Guanethidine—SLC6A2—NRF2 pathway—NQO1—prostate cancer	0.000168	0.00372	CbGpPWpGaD
Guanethidine—SLC6A2—NRF2 pathway—HSPA1A—prostate cancer	0.000167	0.00369	CbGpPWpGaD
Guanethidine—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA2—prostate cancer	0.000166	0.00369	CbGpPWpGaD
Guanethidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP7B1—prostate cancer	0.000166	0.00367	CbGpPWpGaD
Guanethidine—CYP3A4—Xenobiotics—CYP1A1—prostate cancer	0.000162	0.0036	CbGpPWpGaD
Guanethidine—CYP3A4—Tamoxifen metabolism—CYP1A1—prostate cancer	0.000156	0.00346	CbGpPWpGaD
Guanethidine—SLC6A2—NRF2 pathway—EGR1—prostate cancer	0.000156	0.00346	CbGpPWpGaD
Guanethidine—SLC6A2—NRF2 pathway—GGT1—prostate cancer	0.000156	0.00346	CbGpPWpGaD
Guanethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—prostate cancer	0.000155	0.00343	CbGpPWpGaD
Guanethidine—SLC6A2—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.00015	0.00333	CbGpPWpGaD
Guanethidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—prostate cancer	0.000148	0.00328	CbGpPWpGaD
Guanethidine—SLC6A2—NRF2 pathway—RXRA—prostate cancer	0.000146	0.00324	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000145	0.00322	CbGpPWpGaD
Guanethidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A5—prostate cancer	0.000142	0.00315	CbGpPWpGaD
Guanethidine—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—prostate cancer	0.00014	0.00311	CbGpPWpGaD
Guanethidine—SLC6A2—NRF2 pathway—TGFBR2—prostate cancer	0.00014	0.0031	CbGpPWpGaD
Guanethidine—SLC6A2—NRF2 pathway—GSTP1—prostate cancer	0.00014	0.0031	CbGpPWpGaD
Guanethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—prostate cancer	0.000138	0.00306	CbGpPWpGaD
Guanethidine—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—prostate cancer	0.000136	0.00302	CbGpPWpGaD
Guanethidine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—prostate cancer	0.000133	0.00296	CbGpPWpGaD
Guanethidine—SLC6A2—NRF2 pathway—GSTM1—prostate cancer	0.000129	0.00285	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—UGT2B17—prostate cancer	0.000127	0.00281	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—UGT2B15—prostate cancer	0.000127	0.00281	CbGpPWpGaD
Guanethidine—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—prostate cancer	0.000125	0.00278	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—UGT2B17—prostate cancer	0.000125	0.00278	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—SULT2B1—prostate cancer	0.000119	0.00265	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—GSTM3—prostate cancer	0.000119	0.00265	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000118	0.00263	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—SULT2B1—prostate cancer	0.000118	0.00261	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—GSTM3—prostate cancer	0.000118	0.00261	CbGpPWpGaD
Guanethidine—CYP3A4—Tryptophan metabolism—CYP2E1—prostate cancer	0.000116	0.00257	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000115	0.00256	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000115	0.00256	CbGpPWpGaD
Guanethidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—prostate cancer	0.000115	0.00255	CbGpPWpGaD
Guanethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—prostate cancer	0.000114	0.00254	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—CYP3A43—prostate cancer	0.000113	0.00251	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—NAT1—prostate cancer	0.000113	0.00251	CbGpPWpGaD
Guanethidine—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—prostate cancer	0.000113	0.0025	CbGpPWpGaD
Guanethidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—prostate cancer	0.000112	0.00248	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—CYP3A43—prostate cancer	0.000112	0.00247	CbGpPWpGaD
Guanethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—prostate cancer	0.00011	0.00245	CbGpPWpGaD
Guanethidine—CYP3A4—Tryptophan metabolism—CYP1B1—prostate cancer	0.00011	0.00244	CbGpPWpGaD
Guanethidine—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.00011	0.00243	CbGpPWpGaD
Guanethidine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—prostate cancer	0.000109	0.00241	CbGpPWpGaD
Guanethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—prostate cancer	0.000106	0.00234	CbGpPWpGaD
Guanethidine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—prostate cancer	0.000104	0.00231	CbGpPWpGaD
Guanethidine—CYP3A4—Tryptophan metabolism—CYP19A1—prostate cancer	0.000103	0.00229	CbGpPWpGaD
Guanethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—prostate cancer	0.000101	0.00223	CbGpPWpGaD
Guanethidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	9.71e-05	0.00215	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—EPHX1—prostate cancer	9.48e-05	0.0021	CbGpPWpGaD
Guanethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—prostate cancer	9.38e-05	0.00208	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	9.36e-05	0.00208	CbGpPWpGaD
Guanethidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—prostate cancer	9.27e-05	0.00206	CbGpPWpGaD
Guanethidine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—prostate cancer	9.26e-05	0.00205	CbGpPWpGaD
Guanethidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—prostate cancer	8.94e-05	0.00198	CbGpPWpGaD
Guanethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	8.89e-05	0.00197	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—CYP7B1—prostate cancer	8.8e-05	0.00195	CbGpPWpGaD
Guanethidine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	8.77e-05	0.00195	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—CYP7B1—prostate cancer	8.67e-05	0.00192	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—ABCG5—prostate cancer	8.64e-05	0.00192	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—SULT1E1—prostate cancer	8.57e-05	0.0019	CbGpPWpGaD
Guanethidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	8.56e-05	0.0019	CbGpPWpGaD
Guanethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	8.48e-05	0.00188	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—SULT1E1—prostate cancer	8.45e-05	0.00187	CbGpPWpGaD
Guanethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	8.36e-05	0.00185	CbGpPWpGaD
Guanethidine—CYP3A4—Tryptophan metabolism—CYP1A1—prostate cancer	8.33e-05	0.00185	CbGpPWpGaD
Guanethidine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	8.25e-05	0.00183	CbGpPWpGaD
Guanethidine—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	8.16e-05	0.00181	CbGpPWpGaD
Guanethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	8.07e-05	0.00179	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	7.63e-05	0.00169	CbGpPWpGaD
Guanethidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	7.6e-05	0.00169	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—CYP3A5—prostate cancer	7.55e-05	0.00167	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—CYP3A5—prostate cancer	7.44e-05	0.00165	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—GSTA3—prostate cancer	7.29e-05	0.00162	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—GNG5—prostate cancer	7.26e-05	0.00161	CbGpPWpGaD
Guanethidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	7.21e-05	0.0016	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—GSTA3—prostate cancer	7.19e-05	0.00159	CbGpPWpGaD
Guanethidine—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	6.88e-05	0.00152	CbGpPWpGaD
Guanethidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	6.78e-05	0.0015	CbGpPWpGaD
Guanethidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	6.74e-05	0.00149	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—GSTA4—prostate cancer	6.67e-05	0.00148	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	6.67e-05	0.00148	CbGpPWpGaD
Guanethidine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	6.65e-05	0.00147	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	6.57e-05	0.00146	CbGpPWpGaD
Guanethidine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	6.54e-05	0.00145	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—GSTA2—prostate cancer	6.5e-05	0.00144	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	6.42e-05	0.00142	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	6.33e-05	0.0014	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—GSTA1—prostate cancer	6.27e-05	0.00139	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—GSTO1—prostate cancer	6.2e-05	0.00137	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—NAT2—prostate cancer	6.2e-05	0.00137	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—PRKACB—prostate cancer	6.19e-05	0.00137	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	6.11e-05	0.00136	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	6.11e-05	0.00136	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	5.94e-05	0.00132	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	5.86e-05	0.0013	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—NCOA2—prostate cancer	5.83e-05	0.00129	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	5.56e-05	0.00123	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	5.52e-05	0.00122	CbGpPWpGaD
Guanethidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	5.46e-05	0.00121	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	5.45e-05	0.00121	CbGpPWpGaD
Guanethidine—SLC6A2—NRF2 pathway—TGFB1—prostate cancer	5.24e-05	0.00116	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	5.2e-05	0.00115	CbGpPWpGaD
Guanethidine—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	5.14e-05	0.00114	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—HPGDS—prostate cancer	4.95e-05	0.0011	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	4.92e-05	0.00109	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.92e-05	0.00109	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	4.86e-05	0.00108	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—GSTT1—prostate cancer	4.8e-05	0.00107	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	4.75e-05	0.00105	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—RXRA—prostate cancer	4.68e-05	0.00104	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	4.56e-05	0.00101	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	4.55e-05	0.00101	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	4.49e-05	0.000995	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—NCOA2—prostate cancer	4.33e-05	0.000961	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	4.04e-05	0.000896	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	3.98e-05	0.000883	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	3.83e-05	0.000849	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	3.78e-05	0.000837	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—GGT1—prostate cancer	3.71e-05	0.000822	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—NCOA1—prostate cancer	3.65e-05	0.00081	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	3.6e-05	0.000798	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—PPARA—prostate cancer	3.57e-05	0.000792	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	3.55e-05	0.000787	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—RXRA—prostate cancer	3.47e-05	0.00077	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—COMT—prostate cancer	3.35e-05	0.000742	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—GSTP1—prostate cancer	3.33e-05	0.000739	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	3.3e-05	0.000732	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	3.28e-05	0.000728	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—GSTM1—prostate cancer	3.06e-05	0.000679	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	3.02e-05	0.000669	CbGpPWpGaD
Guanethidine—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	2.9e-05	0.000643	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—HAO1—prostate cancer	2.86e-05	0.000635	CbGpPWpGaD
Guanethidine—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	2.86e-05	0.000635	CbGpPWpGaD
Guanethidine—SLC6A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.84e-05	0.000629	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—TST—prostate cancer	2.33e-05	0.000518	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—PSAT1—prostate cancer	2.33e-05	0.000518	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—ADI1—prostate cancer	2.33e-05	0.000518	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—GRHL1—prostate cancer	2.33e-05	0.000518	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CSAD—prostate cancer	2.33e-05	0.000518	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CBR1—prostate cancer	2.33e-05	0.000518	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—UGT2B15—prostate cancer	2.17e-05	0.000481	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—UGT2B17—prostate cancer	2.17e-05	0.000481	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—GRHPR—prostate cancer	2.17e-05	0.000481	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CKMT2—prostate cancer	2.17e-05	0.000481	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—RFK—prostate cancer	2.04e-05	0.000452	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—SULT2B1—prostate cancer	2.04e-05	0.000452	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—NAGLU—prostate cancer	2.04e-05	0.000452	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—MBTPS1—prostate cancer	2.04e-05	0.000452	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—PGAM2—prostate cancer	2.04e-05	0.000452	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—AOX1—prostate cancer	2.04e-05	0.000452	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—GSTM3—prostate cancer	2.04e-05	0.000452	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—NAT1—prostate cancer	1.93e-05	0.000429	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—AMACR—prostate cancer	1.93e-05	0.000429	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.93e-05	0.000429	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.93e-05	0.000429	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—DEGS1—prostate cancer	1.93e-05	0.000429	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.85e-05	0.000409	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—HPGD—prostate cancer	1.64e-05	0.000365	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.64e-05	0.000365	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.55e-05	0.000343	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.5e-05	0.000334	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—MTAP—prostate cancer	1.5e-05	0.000334	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.47e-05	0.000325	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.47e-05	0.000325	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—ACSL4—prostate cancer	1.4e-05	0.00031	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.4e-05	0.00031	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—UMPS—prostate cancer	1.34e-05	0.000297	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—PHGDH—prostate cancer	1.34e-05	0.000297	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—ARG2—prostate cancer	1.34e-05	0.000297	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—LDHB—prostate cancer	1.31e-05	0.000292	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.29e-05	0.000286	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—PDHA1—prostate cancer	1.25e-05	0.000276	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—TCN2—prostate cancer	1.25e-05	0.000276	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—GSTA3—prostate cancer	1.25e-05	0.000276	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—UCP3—prostate cancer	1.25e-05	0.000276	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.19e-05	0.000264	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.19e-05	0.000264	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—GSTA4—prostate cancer	1.14e-05	0.000253	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.14e-05	0.000253	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—GSTA2—prostate cancer	1.11e-05	0.000246	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.1e-05	0.000243	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—ABCG5—prostate cancer	1.1e-05	0.000243	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—GSTA1—prostate cancer	1.07e-05	0.000238	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—GSTO1—prostate cancer	1.06e-05	0.000235	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.06e-05	0.000235	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—NAT2—prostate cancer	1.06e-05	0.000235	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—PLCB2—prostate cancer	1.02e-05	0.000225	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—LRP2—prostate cancer	1.02e-05	0.000225	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.02e-05	0.000225	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—P4HB—prostate cancer	9.96e-06	0.000221	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—SLC22A1—prostate cancer	9.69e-06	0.000215	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—SULT2A1—prostate cancer	9.45e-06	0.000209	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—MED12—prostate cancer	9.29e-06	0.000206	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—GNG5—prostate cancer	9.22e-06	0.000204	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—NCOA3—prostate cancer	8.88e-06	0.000197	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—HPGDS—prostate cancer	8.47e-06	0.000188	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CYP2C19—prostate cancer	8.42e-06	0.000187	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—GSTT1—prostate cancer	8.22e-06	0.000182	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—ACHE—prostate cancer	8.22e-06	0.000182	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CYP2A6—prostate cancer	8.12e-06	0.00018	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—AKR1C3—prostate cancer	7.9e-06	0.000175	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—PRKACB—prostate cancer	7.86e-06	0.000174	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CYP17A1—prostate cancer	7.78e-06	0.000172	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—NCOA2—prostate cancer	7.41e-06	0.000164	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—SLC5A5—prostate cancer	7.07e-06	0.000157	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CYP2E1—prostate cancer	6.91e-06	0.000153	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—NQO1—prostate cancer	6.83e-06	0.000151	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—TH—prostate cancer	6.73e-06	0.000149	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CYP1B1—prostate cancer	6.55e-06	0.000145	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—GGT1—prostate cancer	6.34e-06	0.000141	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—NCOA1—prostate cancer	6.25e-06	0.000139	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CYP19A1—prostate cancer	6.16e-06	0.000137	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—RXRA—prostate cancer	5.94e-06	0.000132	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—COMT—prostate cancer	5.72e-06	0.000127	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—GSTP1—prostate cancer	5.7e-06	0.000126	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—ITPR1—prostate cancer	5.6e-06	0.000124	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—TYMS—prostate cancer	5.3e-06	0.000117	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—GSTM1—prostate cancer	5.23e-06	0.000116	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—LPL—prostate cancer	5.14e-06	0.000114	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.96e-06	0.00011	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—ERCC2—prostate cancer	4.92e-06	0.000109	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—MTHFR—prostate cancer	4.63e-06	0.000103	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—PPARA—prostate cancer	4.54e-06	0.000101	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CAV1—prostate cancer	4.27e-06	9.46e-05	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.89e-06	8.62e-05	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—INS—prostate cancer	3.68e-06	8.16e-05	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—CREBBP—prostate cancer	3.6e-06	7.99e-05	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.42e-06	7.58e-05	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—NOS3—prostate cancer	3.23e-06	7.15e-05	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.98e-06	6.6e-05	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—PTGS2—prostate cancer	2.95e-06	6.54e-05	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—PTEN—prostate cancer	2.57e-06	5.71e-05	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—EP300—prostate cancer	2.45e-06	5.44e-05	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.82e-06	4.03e-05	CbGpPWpGaD
Guanethidine—CYP3A4—Metabolism—AKT1—prostate cancer	1.48e-06	3.29e-05	CbGpPWpGaD
